Alantolactone inhibits cervical cancer progression by downregulating BMI1

Cervical cancer is the second most common cancer in women. Despite advances in cervical cancer therapy, tumor recurrence and metastasis remain the leading causes of mortality. High expression of BMI1 is significantly associated with poor tumor differentiation, high clinical grade, and poor prognosis...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Sci Rep
Prif Awduron: Sun, Xiaodong, Xu, Hongxia, Dai, Tianyu, Xie, Lixia, Zhao, Qiang, Hao, Xincai, Sun, Yan, Wang, Xuanbin, Jiang, Nan, Sang, Ming
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group UK 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8085045/
https://ncbi.nlm.nih.gov/pubmed/33927214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-87781-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg